Human papillomavirus vaccination: Good clinical practice recommendations from the Federation of Obstetric and Gynecological Societies of India-Reference-Cited by-同舟云学术

Human papillomavirus vaccination: Good clinical practice recommendations from the Federation of Obstetric and Gynecological Societies of India

Published:2020-07-06 Issue:9 Volume:46 Page:1651-1660
ISSN:1341-8076
Container-title:Journal of Obstetrics and Gynaecology Research
language:en
Short-container-title:J. Obstet. Gynaecol. Res.

Author:

Bhatla Neerja¹^ORCID,Meena Jyoti¹,Gupta Krishnendu²,Pal Bhaskar³,Divakar Hema⁴,Bhalerao Sarita⁵,Peedicayil Abraham⁶,Srivastava Shikha⁷,Basu Partha⁸,Purandare Chittaranjan Narahari⁹,

Affiliation:

1. All India Institute of Medical Sciences New Delhi India

2. Ramakrishna Mission Seva Pratisthan and Vivekananda Institute of Medical Sciences Kolkata India

3. Apollo Clinic Kolkata India

4. Divakar's Specialty Hospital Bengaluru India

5. Reliance HNH, Saifee and Bhatia Hospitals Mumbai India

6. Christian Medical College Vellore India

7. Population Services International (PSI) Delhi India

8. Early Detection and Prevention Section(EDP)/Screening Group (SCR) International Agency for Research on CancerWorld Health Organization Lyon France

9. Breach Candy Hospital and Research Centre Mumbai India

Publisher

Wiley

Subject

Obstetrics and Gynecology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jog.14345

Reference47 articles.

1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

2. Longitudinal Study of Human Papillomavirus Persistence and Cervical Intraepithelial Neoplasia Grade 2/3: Critical Role of Duration of Infection

3. BruniL AlberoG SerranoBet al. ICO/IARC information Centre on HPV and cancer (HPV information Centre). Human papillomavirus and related diseases in India. Summary Report 17 June2019.

4. Is one dose of human papillomavirus vaccine as effective as three?: A national cohort analysis

5. Can a single dose of human papillomavirus (HPV) vaccine prevent cervical cancer? Early findings from an Indian study

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and immunogenicity of AS04‐HPV‐16/18 vaccine in females with existing cervical HR‐HPV infection at first vaccination: A pooled analysis of four large clinical trials worldwide;International Journal of Cancer;2024-02-17

2. Immunogenicity and safety of a new quadrivalent HPV vaccine in girls and boys aged 9–14 years versus an established quadrivalent HPV vaccine in women aged 15–26 years in India: a randomised, active-controlled, multicentre, phase 2/3 trial;The Lancet Oncology;2023-12

3. Evaluation of cervical cancer screening during pregnancy in India: Human papillomavirus testing can change the paradigm;The National Medical Journal of India;2023-07-18

4. Updates on cervical cancer prevention;International Journal of Gynecologic Cancer;2023-03

5. Recommendations for the prevention, screening, diagnosis, staging, and management of cervical cancer in areas with limited resources: Report from the International Gynecological Cancer Society consensus meeting;Frontiers in Oncology;2022-08-18